Leap Investments’s OptimizeRx OPRX Stock Holding History

Leap Investments’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,122	Closed	-$164K	–	464
2019 Q2	$164K	Buy	+10,122	New	+$137K	0.22%	179

Other funds holding OPRX

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Leap Investments's OPRX Position: Q3 2019 in Review

Leap Investments sold out of OptimizeRx (OPRX) in Q3 2019, closing a stake of 10,122 shares — an estimated $164K sold.

Leap Investments first reported a position in OPRX in Q2 2019 and held it in 1 quarter. The position peaked at $164K in Q2 2019. 64 funds tracked by Wall St. Rank hold OPRX as of Q3 2019.

Leap Investments reported no remaining OptimizeRx position as of Q3 2019 after selling out during the quarter.
Leap Investments sold 10,122 OptimizeRx shares in Q3 2019, an estimated $164K.
Leap Investments first reported a position in OptimizeRx in Q2 2019 and held it in 1 quarter.
Leap Investments's OptimizeRx position peaked at $164K in Q2 2019.
64 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2019.

Based on Leap Investments's 13F filing for Q3 2019, filed 13 Nov 2019.